tiprankstipranks
Trending News
More News >
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
Advertisement

Kalaris Therapeutics (KLRS) Financial Statements

Compare
354 Followers

Kalaris Therapeutics Financial Overview

Kalaris Therapeutics's market cap is currently $93.90M. The company's EPS TTM is $-11.751; its P/E ratio is ―; Kalaris Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Currency in USD

Kalaris Therapeutics Earnings and Revenue History

Kalaris Therapeutics Debt to Assets

Kalaris Therapeutics Cash Flow

Kalaris Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis